Childhood Pneumonia
Conditions
Brief summary
The goal of this clinical trial is to study the impact of sodium supplementation on hospital outcomes of children with pneumonia. It aims to answer: * Does sodium supplementation lower the length of hospital stay in children with pneumonia? * Does potassium supplementation lower the length of hospital stay in children with pneumonia? Researchers will compare the intervention arm to the control arm to see if the intervention lowers the length of hospital stay. Participants will: • Take one sachet of oral rehydration solution (ORS) every day for 3 days.
Detailed description
The study is a randomized clinical trial that will be conducted on hospitalized children with pneumonia after considering exclusion criteria. The enrolled children will be randomly divided into two groups: the intervention group and the control group. The intervention group will receive the ORS daily for 3 days. All children will be followed until discharge from the hospital, and their clinical outcomes will be assessed.
Interventions
one sachet every day for 3 days
Sponsors
Study design
Eligibility
Inclusion criteria
* Infants and children aged between 1 month and 5 years. * Patients diagnosed with pneumonia according to World Health Organization (WHO) criteria.
Exclusion criteria
* Children with other comorbidities. * Those whose parents will show disapproval for the participation of the study. * Children on medications that affect sodium and potassium levels.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The difference in hospital length of stay between hospitalized children with pneumonia who received oral rehydration solution and those who did not receive it | Children will be followed until discharge from the hospital, an average of one week. | Evaluation of effect of oral rehydration solution supplementation by assessing the length of hospital stay |
Countries
Egypt